Celldex Therapeutics (CLDX) Non Operating Income (2010 - 2012)

Celldex Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $105000.0 for Q3 2012.

• In Q3 2012, Non Operating Income fell 27.08% year-over-year to $105000.0; the TTM figure through Sep 2012 stood at $525000.0 (down 75.99% YoY), while the FY2017 annual figure was $326000.0, up 117.33% from the prior year.
• Non Operating Income was $105000.0 for Q3 2012 at Celldex Therapeutics, down from $126000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.9 million in Q4 2010 to a low of $79000.0 in Q2 2011.
• Historically, Non Operating Income has averaged $293100.0 across 3 years, with a median of $114500.0 in 2010.
• The sharpest annual moves came in 2011 and 2012: Non Operating Income slumped 95.27% in 2011, then soared 144.05% in 2012.
• A 3-year view of Non Operating Income shows it stood at $1.9 million in 2010, then plunged by 95.27% to $89000.0 in 2011, then increased by 17.98% to $105000.0 in 2012.
• The last three Non Operating Income figures came in at $105000.0 (Q3 2012), $126000.0 (Q2 2012), and $205000.0 (Q1 2012), per Business Quant data.